QuidelOrtho (QDEL) COO awarded RSUs, stock options and net shares after tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp Chief Operations Officer Philip D. McLellan reported multiple equity compensation transactions. On January 30, 2026, he received 36,152 restricted stock units and 36,150 non-qualified stock options with a $27.17 exercise price, vesting in tranches from 2027 to 2029. On January 31, 2026, several blocks of restricted stock units converted into common stock, increasing his direct holdings, while the company withheld shares at $27.17 per share to cover tax obligations. After these transactions, he directly owned 19,174 shares of common stock, plus the newly granted RSUs and options.
Positive
- None.
Negative
- None.
Insider Trade Summary
4,617 shares exercised/converted
Mixed
14 txns
Insider
McLellan Philip D.
Role
Chief Operations Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,127 | $0.00 | -- |
| Exercise | Restricted Stock Units | 847 | $0.00 | -- |
| Exercise | Restricted Stock Units (Converted) | 2,009 | $0.00 | -- |
| Exercise | Restricted Stock Units (Premium ) | 634 | $0.00 | -- |
| Grant/Award | Common Stock | 1,127 | $0.00 | -- |
| Tax Withholding | Common Stock | 421 | $27.17 | $11K |
| Grant/Award | Common Stock | 847 | $0.00 | -- |
| Tax Withholding | Common Stock | 304 | $27.17 | $8K |
| Grant/Award | Common Stock | 2,009 | $0.00 | -- |
| Tax Withholding | Common Stock | 674 | $27.17 | $18K |
| Grant/Award | Common Stock | 634 | $0.00 | -- |
| Tax Withholding | Common Stock | 228 | $27.17 | $6K |
| Grant/Award | Restricted Stock Units | 36,152 | $0.00 | -- |
| Grant/Award | Non-Qualified Stock Options | 36,150 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Restricted Stock Units (Converted) — 0 shares (Direct);
Restricted Stock Units (Premium ) — 0 shares (Direct);
Common Stock — 17,311 shares (Direct);
Non-Qualified Stock Options — 36,150 shares (Direct)
Footnotes (1)
- Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. 2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026. 846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule.
FAQ
What insider transactions did QuidelOrtho (QDEL) report for COO Philip McLellan?
QuidelOrtho reported equity compensation activity for COO Philip McLellan, including new restricted stock units, stock options, and the release of previously granted RSUs into common stock, along with share withholding to cover related tax obligations.
How many restricted stock units did the QuidelOrtho (QDEL) COO receive?
Philip McLellan received 36,152 restricted stock units. These units represent the right to receive one share of QuidelOrtho common stock each and vest over several years according to the schedule described in the filing footnotes.
What stock options were granted to the QuidelOrtho (QDEL) COO in this Form 4?
The filing shows a grant of 36,150 non-qualified stock options with a $27.17 exercise price. These options vest in equal installments on January 30, 2027, January 30, 2028, and January 30, 2029, subject to continued service conditions.
How do the new QuidelOrtho (QDEL) RSUs for the COO vest over time?
Of the 36,152 new RSUs, 12,050 shares vest on January 30, 2027. The remaining 24,102 shares vest in equal installments on January 30, 2028 and January 30, 2029, according to the vesting schedule in the filing.